Global Pharmaceutical Blockchain 麻豆原创 Research Report 2023

Publication ID:

PB502230997

Publication Date:

February 15, 2023

Pages:

116

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.
Highlights
The global Pharmaceutical Blockchain market was valued at US$ 1812.2 million in 2022 and is anticipated to reach US$ 2214.8 million by 2029, witnessing a CAGR of 3.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91% in 2019.
For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69% in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Blockchain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Blockchain.
The Pharmaceutical Blockchain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharmaceutical Blockchain market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Blockchain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chronicled Inc.
Doc.AI
Embleema
Factom Inc.
FarmaTrust
Guardtime Federal
Hashed Health
IBM Corporation
Medicalchain
Microsoft Corporation
Organizations Mentioned
American Society of Clinical Oncology (ASCO)
Association of Clinical Trials Organizations (ACTO)
Castor EDC
Clinical Supplies Management Holdings, Inc.
ClinicalTrials.gov
Medpace
N-SIDE
Quanticate
Society for Clinical Trials
Segment by Type
Public
Private
Segment by Application
Supply Chian Management
Clinical Data Exchange and Interoperability
Drug Development
Clinical Trials
Internet of Medical Things (IOMT)& Cyber Security
Other Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Blockchain companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Pharmaceutical Blockchain 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Public
1.2.3 Private
1.3 麻豆原创 by Application
1.3.1 Global Pharmaceutical Blockchain 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Supply Chian Management
1.3.3 Clinical Data Exchange and Interoperability
1.3.4 Drug Development
1.3.5 Clinical Trials
1.3.6 Internet of Medical Things (IOMT)& Cyber Security
1.3.7 Other Applications
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Blockchain 麻豆原创 Perspective (2018-2029)
2.2 Pharmaceutical Blockchain Growth Trends by Region
2.2.1 Global Pharmaceutical Blockchain 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmaceutical Blockchain Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Pharmaceutical Blockchain Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Pharmaceutical Blockchain 麻豆原创 Dynamics
2.3.1 Pharmaceutical Blockchain Industry Trends
2.3.2 Pharmaceutical Blockchain 麻豆原创 Drivers
2.3.3 Pharmaceutical Blockchain 麻豆原创 Challenges
2.3.4 Pharmaceutical Blockchain 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Blockchain Players by Revenue
3.1.1 Global Top Pharmaceutical Blockchain Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical Blockchain Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Pharmaceutical Blockchain 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Blockchain Revenue
3.4 Global Pharmaceutical Blockchain 麻豆原创 Concentration Ratio
3.4.1 Global Pharmaceutical Blockchain 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Blockchain Revenue in 2022
3.5 Pharmaceutical Blockchain Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Blockchain Product Solution and Service
3.7 Date of Enter into Pharmaceutical Blockchain 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Blockchain Breakdown Data by Type
4.1 Global Pharmaceutical Blockchain Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Pharmaceutical Blockchain Forecasted 麻豆原创 Size by Type (2024-2029)
5 Pharmaceutical Blockchain Breakdown Data by Application
5.1 Global Pharmaceutical Blockchain Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Pharmaceutical Blockchain Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical Blockchain 麻豆原创 Size (2018-2029)
6.2 North America Pharmaceutical Blockchain 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmaceutical Blockchain 麻豆原创 Size by Country (2018-2023)
6.4 North America Pharmaceutical Blockchain 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Blockchain 麻豆原创 Size (2018-2029)
7.2 Europe Pharmaceutical Blockchain 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmaceutical Blockchain 麻豆原创 Size by Country (2018-2023)
7.4 Europe Pharmaceutical Blockchain 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Blockchain 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Pharmaceutical Blockchain 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmaceutical Blockchain 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical Blockchain 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Blockchain 麻豆原创 Size (2018-2029)
9.2 Latin America Pharmaceutical Blockchain 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmaceutical Blockchain 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Pharmaceutical Blockchain 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Blockchain 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Pharmaceutical Blockchain 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmaceutical Blockchain 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical Blockchain 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chronicled Inc.
11.1.1 Chronicled Inc. Company Detail
11.1.2 Chronicled Inc. Business Overview
11.1.3 Chronicled Inc. Pharmaceutical Blockchain Introduction
11.1.4 Chronicled Inc. Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.1.5 Chronicled Inc. Recent Development
11.2 Doc.AI
11.2.1 Doc.AI Company Detail
11.2.2 Doc.AI Business Overview
11.2.3 Doc.AI Pharmaceutical Blockchain Introduction
11.2.4 Doc.AI Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.2.5 Doc.AI Recent Development
11.3 Embleema
11.3.1 Embleema Company Detail
11.3.2 Embleema Business Overview
11.3.3 Embleema Pharmaceutical Blockchain Introduction
11.3.4 Embleema Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.3.5 Embleema Recent Development
11.4 Factom Inc.
11.4.1 Factom Inc. Company Detail
11.4.2 Factom Inc. Business Overview
11.4.3 Factom Inc. Pharmaceutical Blockchain Introduction
11.4.4 Factom Inc. Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.4.5 Factom Inc. Recent Development
11.5 FarmaTrust
11.5.1 FarmaTrust Company Detail
11.5.2 FarmaTrust Business Overview
11.5.3 FarmaTrust Pharmaceutical Blockchain Introduction
11.5.4 FarmaTrust Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.5.5 FarmaTrust Recent Development
11.6 Guardtime Federal
11.6.1 Guardtime Federal Company Detail
11.6.2 Guardtime Federal Business Overview
11.6.3 Guardtime Federal Pharmaceutical Blockchain Introduction
11.6.4 Guardtime Federal Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.6.5 Guardtime Federal Recent Development
11.7 Hashed Health
11.7.1 Hashed Health Company Detail
11.7.2 Hashed Health Business Overview
11.7.3 Hashed Health Pharmaceutical Blockchain Introduction
11.7.4 Hashed Health Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.7.5 Hashed Health Recent Development
11.8 IBM Corporation
11.8.1 IBM Corporation Company Detail
11.8.2 IBM Corporation Business Overview
11.8.3 IBM Corporation Pharmaceutical Blockchain Introduction
11.8.4 IBM Corporation Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.8.5 IBM Corporation Recent Development
11.9 Medicalchain
11.9.1 Medicalchain Company Detail
11.9.2 Medicalchain Business Overview
11.9.3 Medicalchain Pharmaceutical Blockchain Introduction
11.9.4 Medicalchain Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.9.5 Medicalchain Recent Development
11.10 Microsoft Corporation
11.10.1 Microsoft Corporation Company Detail
11.10.2 Microsoft Corporation Business Overview
11.10.3 Microsoft Corporation Pharmaceutical Blockchain Introduction
11.10.4 Microsoft Corporation Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.10.5 Microsoft Corporation Recent Development
11.11 Organizations Mentioned
11.11.1 Organizations Mentioned Company Detail
11.11.2 Organizations Mentioned Business Overview
11.11.3 Organizations Mentioned Pharmaceutical Blockchain Introduction
11.11.4 Organizations Mentioned Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.11.5 Organizations Mentioned Recent Development
11.12 American Society of Clinical Oncology (ASCO)
11.12.1 American Society of Clinical Oncology (ASCO) Company Detail
11.12.2 American Society of Clinical Oncology (ASCO) Business Overview
11.12.3 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Introduction
11.12.4 American Society of Clinical Oncology (ASCO) Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.12.5 American Society of Clinical Oncology (ASCO) Recent Development
11.13 Association of Clinical Trials Organizations (ACTO)
11.13.1 Association of Clinical Trials Organizations (ACTO) Company Detail
11.13.2 Association of Clinical Trials Organizations (ACTO) Business Overview
11.13.3 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Introduction
11.13.4 Association of Clinical Trials Organizations (ACTO) Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.13.5 Association of Clinical Trials Organizations (ACTO) Recent Development
11.14 Castor EDC
11.14.1 Castor EDC Company Detail
11.14.2 Castor EDC Business Overview
11.14.3 Castor EDC Pharmaceutical Blockchain Introduction
11.14.4 Castor EDC Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.14.5 Castor EDC Recent Development
11.15 Clinical Supplies Management Holdings, Inc.
11.15.1 Clinical Supplies Management Holdings, Inc. Company Detail
11.15.2 Clinical Supplies Management Holdings, Inc. Business Overview
11.15.3 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Introduction
11.15.4 Clinical Supplies Management Holdings, Inc. Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.15.5 Clinical Supplies Management Holdings, Inc. Recent Development
11.16 ClinicalTrials.gov
11.16.1 ClinicalTrials.gov Company Detail
11.16.2 ClinicalTrials.gov Business Overview
11.16.3 ClinicalTrials.gov Pharmaceutical Blockchain Introduction
11.16.4 ClinicalTrials.gov Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.16.5 ClinicalTrials.gov Recent Development
11.17 Medpace
11.17.1 Medpace Company Detail
11.17.2 Medpace Business Overview
11.17.3 Medpace Pharmaceutical Blockchain Introduction
11.17.4 Medpace Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.17.5 Medpace Recent Development
11.18 N-SIDE
11.18.1 N-SIDE Company Detail
11.18.2 N-SIDE Business Overview
11.18.3 N-SIDE Pharmaceutical Blockchain Introduction
11.18.4 N-SIDE Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.18.5 N-SIDE Recent Development
11.19 Quanticate
11.19.1 Quanticate Company Detail
11.19.2 Quanticate Business Overview
11.19.3 Quanticate Pharmaceutical Blockchain Introduction
11.19.4 Quanticate Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.19.5 Quanticate Recent Development
11.20 Society for Clinical Trials
11.20.1 Society for Clinical Trials Company Detail
11.20.2 Society for Clinical Trials Business Overview
11.20.3 Society for Clinical Trials Pharmaceutical Blockchain Introduction
11.20.4 Society for Clinical Trials Revenue in Pharmaceutical Blockchain Business (2018-2023)
11.20.5 Society for Clinical Trials Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Chronicled Inc.
Doc.AI
Embleema
Factom Inc.
FarmaTrust
Guardtime Federal
Hashed Health
IBM Corporation
Medicalchain
Microsoft Corporation
Organizations Mentioned
American Society of Clinical Oncology (ASCO)
Association of Clinical Trials Organizations (ACTO)
Castor EDC
Clinical Supplies Management Holdings, Inc.
ClinicalTrials.gov
Medpace
N-SIDE
Quanticate
Society for Clinical Trials

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.